Dabur: On a roll... - Views on News from Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

StockSelect
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Dabur: On a roll...

May 6, 2004

Ayurvedic products major, Dabur, continued its strong growth momentum in the March quarter. The company has recorded over 13% topline growth and nearly 47% net profit growth during the quarter. For FY04, the company has clocked 9.5% topline and 41% bottomline growth. Please note that these results represent Dabur's standalone India operations excluding its pharma business.

Dabur India (standalone)
(Rs m) 4QFY03 4FY04 Change FY03 FY04 Change
Net Sales 2,542 2,879 13.3% 10,485 11,480 9.5%
Other Income 28 56 98.9% 49 111 125.1%
Expenditure 2,325 2,589 11.3% 9,438 10,229 8.4%
Operating Profit (EBDIT) 217 291 34.3% 1,047 1,250 19.4%
Operating Profit Margin (%) 8.5% 10.1%   10.0% 10.9%  
Interest 11 4 -65.1% 119 69 -42.1%
Depreciation 49 41 -15.7% 177 158 -11.2%
Profit before Tax 185 302 63.0% 800 1,134 41.8%
Tax (including deferred tax) 4 36 797.5% 80 122 52.6%
Profit after Tax 181 266 46.8% 720 1,012 40.6%
Net profit margin (%) 7.1% 9.2%   6.9% 8.8%  
Effective tax rate (%) 2.2% 11.9%   10.0% 10.8%  
No. of shares (m) 285.7 286.2   285.7 286.2  
Diluted earnings per share (Rs)* 2.5 3.7   2.5 3.5  
P/E ratio (x)         23.9  
(*annualised)            

To Read the Full Story, Subscribe or Sign In
To Read the Full Story, Subscribe or Sign In


Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

DABUR SHARE PRICE


Sep 22, 2020 (Close)

TRACK DABUR

DABUR - ITC COMPARISON

COMPARE DABUR WITH

MARKET STATS